Association Between Stress Hormones and Menopausal Symptoms in Iraqi Postmenopausal Women
Keywords:
Cortisol, ACTH, DHEA, Premenopausal, PostmenopausalAbstract
There is increasing evidence that dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis may play a role in the etiology and severity of symptoms of menopause but the data are scarce regarding stress hormones in postmenopausal women with limited data from Middle Eastern population. The aim of this study was to examine serum levels of cortisol, ACTH, and DHEA and their associations with menopausal symptoms in postmenopausal women in Iraq. We used a cross-sectional comparative design including 68 postmenopausal women and 42 age-matched premenopausal controls. The information regarding menopausal symptoms was obtained via structured questionnaires, meanwhile, serum cortisol, ACTH, and DHEA concentrations were measured by enzyme-linked immuno-sorbent assay (ELISA). Cortisol in postmenopausal women had significantly higher concentrations of cortisol (18.6 ± 4.2 µg/dL vs. 13.9 ± 3.6 µg/dL, P < 0.02) and ACTH (46.3 ± 10.8 pg/mL vs. 38.1 ± 9.4 pg/mL, P < 0.03), along with significantly lower concentrations of DHEA (88.21 ± 12.3 µg/dL vs. 95.4 ± 18.9 µg/dL, P < 0.017), compared with premenopausal women. Postmenopausal participants experienced significantly higher prevalence of menopausal symptoms, especially hot flashes (78.0%), sleep disturbances (69.1%), and mood disturbances (64.7%). Hot flashes (P=0.02; P=0.01), sleep disturbance (P=0.03; P=0.04), and mood disturbances (P=0.04; P=0.02) were significantly associated with elevated cortisol and ACTH levels, respectively. By contrast, lower DHEA was independently associated with lack of libido (P = 0.001) and vaginal dryness (P = 0.03). Such stress hormone imbalance is associated with menopausal symptomatology, which suggests that stress-related hormonal assessment should be included to the bedside evaluation of postmenopausal women.
References
Abdulkarim, A. M., Saeed, M. H., & Hassan, A. M. (2024). Assessment of Symptoms of Depression and Anxiety among Menopause Women in Sulaimani City, Kurdistan: Cross-sectional Study. UHD Journal of Science and Technology, 8(1), 115–121. https://doi.org/10.21928/uhdjst.v8n1y2024.pp115-121
Bose, M., Oliván, B., & Laferrère, B. (2009). Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Current opinion in endocrinology, diabetes, and obesity, 16(5), 340–346. https://doi.org/10.1097/MED.0b013e32832fa137
Cay, M., Ucar, C., Senol, D., Cevirgen, F., Ozbag, D., Altay, Z., & Yildiz, S. (2018). Effect of increase in cortisol level due to stress in healthy young individuals on dynamic and static balance scores. Northern clinics of Istanbul, 5(4), 295–301. https://doi.org/10.14744/nci.2017.42103
Chua, C. K., Henderson, V. W., Dennerstein, L., Ames, D., & Szoeke, C. (2014). Dehydroepiandrosterone sulfate and cognition in midlife, post-menopausal women. Neurobiology of aging, 35(7), 1654–1655. https://doi.org/10.1016/j.neurobiolaging.2014.01.140
Davis, S. R., Davison, S. L., Donath, S., & Bell, R. J. (2005). Circulating androgen levels and self-reported sexual function in women. JAMA, 294(1), 91–96. https://doi.org/10.1001/jama.294.1.91
Freedman R. R. (2005). Hot flashes: behavioral treatments, mechanisms, and relation to sleep. The American journal of medicine, 118 Suppl 12B, 124–130. https://doi.org/10.1016/j.amjmed.2005.09.046
Hantsoo, L., Jagodnik, K. M., Novick, A. M., Baweja, R., di Scalea, T. L., Ozerdem, A., McGlade, E. C., Simeonova, D. I., Dekel, S., Kornfield, S. L., Nazareth, M., & Weiss, S. J. (2023). The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions. Frontiers in endocrinology, 14, 1295261. https://doi.org/10.3389/fendo.2023.1295261
Kalesnikava, V. A., Clarke, P. J., Mukherjee, B., Sen, S., & Mezuk, B. (2022). Psychosocial Stress and Hypothalamic-Pituitary-Adrenal Axis Stress Reactivity: Variations by Race and Socioeconomic Status Among Adults at Risk of Diabetes. Psychosomatic medicine, 84(7), 813–821. https://doi.org/10.1097/PSY.0000000000001112
Kaya, C., Cengiz, H., Yeşil, A., Ekin, M., & Yaşar, L. (2017). The relation among steroid hormone levels, lipid profile and menopausal symptom severity. Journal of psychosomatic obstetrics and gynaecology, 38(4), 284–291. https://doi.org/10.1080/0167482X.2017.1321633
Kirschbaum, C., & Hellhammer, D. H. (1994). Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology, 19(4), 313–333. https://doi.org/10.1016/0306-4530(94)90013-2
Motlani, V., Motlani, G., Pamnani, S., Sahu, A., & Acharya, N. (2023). Endocrine Changes in Postmenopausal Women: A Comprehensive View. Cureus, 15(12), e51287. https://doi.org/10.7759/cureus.51287
Orentreich, N., Brind, J. L., Rizer, R. L., & Vogelman, J. H. (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. The Journal of clinical endocrinology and metabolism, 59(3), 551–555. https://doi.org/10.1210/jcem-59-3-551
Portman, D. J., Gass, M. L., & Vulvovaginal Atrophy Terminology Consensus Conference Panel (2014). Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Maturitas, 79(3), 349–354. https://doi.org/10.1016/j.maturitas.2014.07.013
Sic, A., Cvetkovic, K., Manchanda, E., & Knezevic, N. N. (2024). Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases. Diseases (Basel, Switzerland), 12(9), 220. https://doi.org/10.3390/diseases12090220
Traish, A. M., Vignozzi, L., Simon, J. A., Goldstein, I., & Kim, N. N. (2018). Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. Sexual medicine reviews, 6(4), 558–571. https://doi.org/10.1016/j.sxmr.2018.03.005
Woods, N. F., Carr, M. C., Tao, E. Y., Taylor, H. J., & Mitchell, E. S. (2006). Increased urinary cortisol levels during the menopausal transition. Menopause (New York, N.Y.), 13(2), 212–221. https://doi.org/10.1097/01.gme.0000198490.57242.2e
Woods, N. F., Mitchell, E. S., & Smith-Dijulio, K. (2009). Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause (New York, N.Y.), 16(4), 708–718. https://doi.org/10.1097/gme.0b013e318198d6b2
Yuksel, D., de Zambotti, M., Sugarbaker, D., Schulte, T., Colrain, I. M., & Baker, F. C. (2021). Physiological responses to acute psychosocial stress in women with menopausal insomnia. International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 164, 87–94. https://doi.org/10.1016/j.ijpsycho.2021.02.019
